DIMETANE Drug Patent Profile
✉ Email this page to a colleague
When do Dimetane patents expire, and when can generic versions of Dimetane launch?
Dimetane is a drug marketed by Wyeth Cons, Robins Ah, and Wyeth Ayerst. and is included in three NDAs.
The generic ingredient in DIMETANE is brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride profile page.
Summary for DIMETANE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Patent Applications: | 1,436 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DIMETANE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DIMETANE
US Patents and Regulatory Information for DIMETANE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Cons | DIMETANE | brompheniramine maleate | TABLET, EXTENDED RELEASE;ORAL | 010799-010 | Jun 10, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Robins Ah | DIMETANE-DX | brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride | SYRUP;ORAL | 019279-001 | Aug 24, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Cons | DIMETANE | brompheniramine maleate | TABLET, EXTENDED RELEASE;ORAL | 010799-011 | Jun 10, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |